Orthodox Street Overview
- 128k sq ft (12k sq m)
- Main Building: 115k sq ft
- QC Building: 13k sq ft
- R&D Manufacturing and Labs
- QC Lab
- Commercial scale manufacturing
- Capabilities include: blending, granulation, drying, encapsulation, and compression
- Current Manufacturing Capacity: 3Bn tablets and capsules
- Manufacturing License for DEA Schedules II, 2N, III, 3N, IV, L1
- High Potency Manufacturing Suite
- GMP Manufacturing and Lab Facilities
- 12 commercial tablet presses, 5 capsule fillers
- Clinical trial manufacturing suites (bench & pilot)
- 2 Analytical laboratories housing over 100 instruments
- 12 commercial tablet presses, 5 capsule fillers
- Controlled Drug Storage (CRX) Cage & Vault
- Last FDA Inspections – (1) GMP in 2019 with 1 Observation and (2) PAI in 2021 with no observations
